Motion and recovery after Minuteman G5 lumbar fusion
Official title: The Stability Study: Open-Label, Multi-Center, Post-Market Study of Functional Motion Outcomes In Subjects Treated With the Spinal Simplicity Minuteman G5 Fusion Plate
Run by Spinal Simplicity LLC · NCT06355791 · Data updated 2026-11-12
This trial will test whether the Minuteman G5 fusion plate plus bone graft improves walking, balance, pain, and quality of life for adults with degenerative lumbar spine disease and neurogenic claudication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Spinal Simplicity LLC Industry-sponsored |
| Locations | 7 sites (Newnan, Georgia and 6 other locations) |
| Status | Recruiting |
| Started | May 29, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2030 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT06355791 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with degenerative lumbar spine conditions causing chronic low back pain, lower extremity symptoms, and neurogenic claudication who have not improved after at least three months of conservative care and are candidates for the Minuteman G5 per its labeled indication.
✕Probably not a fit
Patients who have other non-spinal causes of leg symptoms, active infection, very poor bone quality, or who are not appropriate surgical candidates are unlikely to benefit from this fusion device.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an open-label, single-arm post-market study enrolling up to 150 adults treated with the Minuteman G5 MIS fusion plate and bone graft at multiple U.S. centers. Subjects will be followed at 1, 3, 6, and 12 months after treatment with gait and balance testing using BioMech Lab sensors to capture three-dimensional motion and mobile-device analysis, alongside patient-reported outcome measures for pain, quality of life, and satisfaction. A CT scan to evaluate fusion will be offered at the 12-month visit, and participants will be asked to complete annual remote or in-person PROMs and safety reviews through year five. The study collects objective motion data and standard clinical outcomes to characterize functional recovery after device implantation.
Why it matters
Potential benefit: If successful, the device could help improve walking, balance, pain, and overall function for people with degenerative lumbar disease and neurogenic claudication.
How similar studies have gone: Minimally invasive lumbar fusion devices have previously shown improvements in pain and function, but device-specific, motion-capture outcomes of this type are limited in the literature.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria A subject must MEET ALL of the following inclusion criteria: 1. Be a candidate for Spinal Simplicity Minuteman G5 Fusion Plate device per labeled indication 2. Be willing and capable of giving written consent to participate in this clinical study based on voluntary agreement after a thorough explanation of the subject's participation has been provided 3. Be willing and capable of subjective evaluation, read and understand written questionnaires, and read, understand the written informed consent 4. Be 18 years of age or older at the time of enrollment 5. Have been diagnosed with degenerative conditions of the lumbar spine resulting in chronic low back pain with lower extremity symptoms and concurrent neurogenic claudication 6. Received at least 3 months of non-operative or conservative treatment without significant benefit in the opinion of the Investigator 7. Be willing and able to comply with study-related requirements, procedures and visits 8. Be on a stable pain medication regimen, as determined by the Investigator, for at least 30 days prior to enrolling in this study. 9. Must disclose any unresolved major issues of secondary gain (e.g., social, financial, legal), as determined by the Investigator. Including being involved in an injury claim under current litigation or has a pending or approved worker's compensation claim. Subjects will not be excluded due to secondary gain, but it should be disclosed at Enrollment. Exclusion Criteria A subject must NOT MEET ANY of the following exclusion criteria: 1. Had previous spinal surgery at the level of intervention (e.g. lumbar fusion, discectomy, Laminectomy) MILD procedure is not considered an exclusion. 2. Patient physically unable to perform the Gait and/or Balance tests. 3. Current systemic infection or local infection increasing the risk of surgery 4. History of medications decreasing bone quality or soft tissue healing in the opinion of the Investigator 5. Grade II-V spondylolisthesis 6. Significant scoliosis with Cobb angle \>10 degrees 7. Unremitting back pain in a spinal flexion position 8. Active systemic disease that may affect the welfare of the subject in the opinion of the Investigator 9. Be concurrently participating in another clinical drug and/or device study that may alter or confound the results of the assessment (investigational device, investigational drug, new indication for a device or drug, or additional testing beyond standard of care procedures) as determined by the investigator. 10. Vertebral osteoporosis or history of vertebral fracture 11. Be pregnant/ lactating or plan to become pregnant from study enrollment through 3 months post-operatively. (determined by urine testing unless female subject is surgical sterile or post-menopausal). If female, sexually active and childbearing age, subject must be willing to use a reliable form of birth control through the 3-month visit. 12. Malformation or dysplasia of spinous process 13. Severe osteoporosis with T score \<-2.5 SD
Where it's running
-
Vista Clinical Research
Newnan, Georgia, United States Recruiting -
Comprehensive Pain & Spine Specialists
Indianapolis, Indiana, United States Recruiting -
Paradigm Health System
Slidell, Louisiana, United States Recruiting -
Nura Precision Pain Management
Edina, Minnesota, United States Recruiting -
Pacific Sports & Spine
Eugene, Oregon, United States Recruiting -
Spine & Nerve Center of the Virginias
Charleston, West Virginia, United States Recruiting
Show 1 more location
-
University of Kansas Medical Center
Kansas City, Kansas, United States Not yet recruiting
Study contacts
- Study coordinator: Echo Cundiff
- Email: ecundiff@spinalsimplicity.com
- Phone: 913-451-4414
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of Irrigation Pressure on Postoperative Complications and Surgical Field Clarity in Unilateral Biportal Endoscopic Spine Surgery
This study tests whether the height of the irrigation fluid bag and the direction of the surgical cut affect fluid pressure, visibility, and early recovery in adults undergoing unilateral biportal endoscopic spine surgery.
-
Microdecompression alone vs. decompression with fusion in adjacent segment stenosis
This trial tests whether a less invasive microdecompression can work as well as adding a fusion extension for people with adjacent segment stenosis after prior lumbar fusion.
-
PMCF look at METROSAN spinal systems and BONEGRAFT materials in adults after spine surgery
This PMCF study tests the safety and performance of METROSAN Titania spinal systems and Bonegraft materials in adults undergoing spinal fusion or stabilization in routine practice.
-
Comparison of two TLIF procedures for single-level lumbar spinal stenosis
This trial tests two minimally invasive TLIF procedures (LUSE-TLIF and MIS-TLIF) to see which better helps people with single-level lumbar spinal stenosis who have not improved with non-surgical treatments.
-
Opioid-free versus opioid-based anesthesia for elective lumbar spine surgery
This test compares opioid-free multimodal anesthesia (with or without an erector spinae plane block) against opioid-containing anesthesia in adults having elective lumbar spine surgery to see which controls pain better and reduces opioid need in the first 48 hours after surgery.
-
Prevalence of PAD in Patients With Surgically Treated Lumbar Spinal Stenosis
This study tests how common peripheral artery disease is in people who have lumbar spinal stenosis and are being considered for, or have had, surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.